S'abonner

The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women - 09/09/11

Doi : 10.1016/S0022-3476(98)70445-7 
Anna-Barbara Moscicki, MD, Stephen Shiboski, PhD, Jeannette Broering, MPH, MSN, Kimberly Powell, MSN, Lisa Clayton, Naomi Jay, MSN, Teresa M. Darragh, MD, Robert Brescia, MD, Saul Kanowitz, MPH, Susanna B. Miller, BA, Joanna Stone, BA, Evelyn Hanson, MSN, Joel Palefsky, MD

Abstract

Objectives: The objectives of this study were to describe the early natural history of human papillomavirus (HPV) infection by examining a cohort of young women positive for an HPV test and to define within this cohort (1) the probability of HPV regression, (2) the risk of having a squamous intraepithelial lesion, and (3) factors that were associated with HPV regression.

Study design: The study was a cohort analytic design. An inception cohort of 618 women positive for HPV participated. HPV testing, cytologic evaluation, and colposcopic evaluation were performed at 4-month intervals. HPV testing was characterized for two groups: low risk (five types rarely associated with cancers) and high risk (nine types most commonly associated with cancers).

Results: Estimates provided by Kaplan-Meier curves showed that ~70% of women were found to have HPV regression by 24 months. Women with low-risk HPV type infections were more likely to show HPV regression than were women with high-risk HPV type infections (log rank test p = 0.002). The relative risk for the development of high-grade squamous intraepithelial lesion (HSIL) was 14.1 (95% confidence interval: 2.3, 84.5) for women with at least three positive tests for high-risk HPV preceding the development of the HSIL compared with that for women with negative tests for high-risk HPV. However, 88% of women with persistent positive HPV tests have not had HSIL to date. No factors associated with high-risk HPV type regression were identified except for a negative association with an incident history of vulvar condyloma (relative risk = 0.5 [95% confidence interval: 0.3 to 0.8]).

Conclusion: Most young women with a positive HPV test will become negative within a 24-month period. Persistent positive tests with oncogenic HPV types represented a significant risk for the development of HSIL. However, we found that most young women with persistent positive HPV tests did not have cytologically perceptible HSIL over a 2-year period. Factors thought to be associated with the development of HSIL were found not to be important in HPV regression. (J Pediatr 1998;132:277-84)

Le texte complet de cet article est disponible en PDF.

Abbreviations : CIN, HPV, HSIL, LSIL, PCR


Plan


 From the Division of Adolescent Medicine, Department of Pediatrics, the Department of Epidemiology and Biostatistics, the Department of Laboratory Medicine and Stomatology, and the Department of Anatomic Pathology, University of California, San Francisco.
 Supported in part by National Cancer Institute No. R01CA51323 and No. R01CA54053, NIAIDS No. P01A121912, National Institutes of Health grant No. M01 RR01271, Maternal and Child Health Bureau Training Grant No. MCJ000978, the Cigarette and Tobacco Surtax Fund of the State of California through the Tobacco-related Research Program of the University of California, grant No. RT 487 and grant No. RT 484, AIDS Clinical Research Center, University of California, San Francisco.
 Reprint requests: Anna-Barbara Moscicki, MD, 400 Parnassus Ave., Room AC-01, Box 0503, San Francisco, CA 94143.
 0022-3476/98/$5.00 + 0  9/21/83685


© 1998  Mosby, Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 132 - N° 2

P. 277-284 - février 1998 Retour au numéro
Article précédent Article précédent
  • Do infants with cystic fibrosis need a protein hydrolysate formula? A prospective, randomized, comparative study
  • Lynda Ellis, Daina Kalnins, Mary Corey, Joan Brennan, Paul Pencharz, Peter Durie
| Article suivant Article suivant
  • Congenital and perinatal cytomegalovirus infection in infants born to mothers infected with human immunodeficiency virus
  • Marisa M. Mussi-Pinhata, Aparecida Y. Yamamoto, Luiz T.M. Figueiredo, Maria C. Cervi, Geraldo Duarte

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.